These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18632810)

  • 1. Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease.
    Tomasi G; Edison P; Bertoldo A; Roncaroli F; Singh P; Gerhard A; Cobelli C; Brooks DJ; Turkheimer FE
    J Nucl Med; 2008 Aug; 49(8):1249-56. PubMed ID: 18632810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195.
    Anderson AN; Pavese N; Edison P; Tai YF; Hammers A; Gerhard A; Brooks DJ; Turkheimer FE
    Neuroimage; 2007 May; 36(1):28-37. PubMed ID: 17398120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global-two-stage filtering of clinical PET parametric maps: application to [(11)C]-(R)-PK11195.
    Tomasi G; Bertoldo A; Cobelli C; Pavese N; Tai YF; Hammers A; Turkheimer FE
    Neuroimage; 2011 Apr; 55(3):942-53. PubMed ID: 21195193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.
    Banati RB; Newcombe J; Gunn RN; Cagnin A; Turkheimer F; Heppner F; Price G; Wegner F; Giovannoni G; Miller DH; Perkin GD; Smith T; Hewson AK; Bydder G; Kreutzberg GW; Jones T; Cuzner ML; Myers R
    Brain; 2000 Nov; 123 ( Pt 11)():2321-37. PubMed ID: 11050032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography study.
    Schuitemaker A; Kropholler MA; Boellaard R; van der Flier WM; Kloet RW; van der Doef TF; Knol DL; Windhorst AD; Luurtsema G; Barkhof F; Jonker C; Lammertsma AA; Scheltens P; van Berckel BN
    Neurobiol Aging; 2013 Jan; 34(1):128-36. PubMed ID: 22840559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reference and target region modeling of [11C]-(R)-PK11195 brain studies.
    Turkheimer FE; Edison P; Pavese N; Roncaroli F; Anderson AN; Hammers A; Gerhard A; Hinz R; Tai YF; Brooks DJ
    J Nucl Med; 2007 Jan; 48(1):158-67. PubMed ID: 17204713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.
    Zhou Y; Resnick SM; Ye W; Fan H; Holt DP; Klunk WE; Mathis CA; Dannals R; Wong DF
    Neuroimage; 2007 Jun; 36(2):298-312. PubMed ID: 17449282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.
    Edison P; Archer HA; Gerhard A; Hinz R; Pavese N; Turkheimer FE; Hammers A; Tai YF; Fox N; Kennedy A; Rossor M; Brooks DJ
    Neurobiol Dis; 2008 Dec; 32(3):412-9. PubMed ID: 18786637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy.
    Gerhard A; Trender-Gerhard I; Turkheimer F; Quinn NP; Bhatia KP; Brooks DJ
    Mov Disord; 2006 Jan; 21(1):89-93. PubMed ID: 16108021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease.
    Tondo G; Iaccarino L; Caminiti SP; Presotto L; Santangelo R; Iannaccone S; Magnani G; Perani D
    Alzheimers Res Ther; 2020 Apr; 12(1):50. PubMed ID: 32354345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A microPET study of the regional distribution of [11C]-PK11195 binding following temporary focal cerebral ischemia in the rat. Correlation with post mortem mapping of microglia activation.
    Hughes JL; Jones PS; Beech JS; Wang D; Menon DK; Aigbirhio FI; Fryer TD; Baron JC
    Neuroimage; 2012 Feb; 59(3):2007-16. PubMed ID: 22056528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of reference regions for (R)-[(11)C]PK11195 studies in Alzheimer's disease and mild cognitive impairment.
    Kropholler MA; Boellaard R; van Berckel BN; Schuitemaker A; Kloet RW; Lubberink MJ; Jonker C; Scheltens P; Lammertsma AA
    J Cereb Blood Flow Metab; 2007 Dec; 27(12):1965-74. PubMed ID: 17406654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography.
    Cumming P; Pedersen MD; Minuzzi L; Mezzomo K; Danielsen EH; Iversen P; Aagaard D; Keiding S; Munk OL; Finsen B
    Synapse; 2006 Jun; 59(7):418-26. PubMed ID: 16485266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.
    Gerhard A; Pavese N; Hotton G; Turkheimer F; Es M; Hammers A; Eggert K; Oertel W; Banati RB; Brooks DJ
    Neurobiol Dis; 2006 Feb; 21(2):404-12. PubMed ID: 16182554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depiction of microglial activation in aging and dementia: Positron emission tomography with [
    Yokokura M; Terada T; Bunai T; Nakaizumi K; Takebayashi K; Iwata Y; Yoshikawa E; Futatsubashi M; Suzuki K; Mori N; Ouchi Y
    J Cereb Blood Flow Metab; 2017 Mar; 37(3):877-889. PubMed ID: 27117856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy.
    Cagnin A; Taylor-Robinson SD; Forton DM; Banati RB
    Gut; 2006 Apr; 55(4):547-53. PubMed ID: 16210399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET.
    Venneti S; Lopresti BJ; Wang G; Hamilton RL; Mathis CA; Klunk WE; Apte UM; Wiley CA
    Neurobiol Aging; 2009 Aug; 30(8):1217-26. PubMed ID: 18178291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vivo measurement of activated microglia in dementia.
    Cagnin A; Brooks DJ; Kennedy AM; Gunn RN; Myers R; Turkheimer FE; Jones T; Banati RB
    Lancet; 2001 Aug; 358(9280):461-7. PubMed ID: 11513911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease.
    Parbo P; Ismail R; Hansen KV; Amidi A; Mårup FH; Gottrup H; Brændgaard H; Eriksson BO; Eskildsen SF; Lund TE; Tietze A; Edison P; Pavese N; Stokholm MG; Borghammer P; Hinz R; Aanerud J; Brooks DJ
    Brain; 2017 Jul; 140(7):2002-2011. PubMed ID: 28575151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease.
    Yokokura M; Mori N; Yagi S; Yoshikawa E; Kikuchi M; Yoshihara Y; Wakuda T; Sugihara G; Takebayashi K; Suda S; Iwata Y; Ueki T; Tsuchiya KJ; Suzuki K; Nakamura K; Ouchi Y
    Eur J Nucl Med Mol Imaging; 2011 Feb; 38(2):343-51. PubMed ID: 20844871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.